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Factors that increase colonic cell turnover, such as local
trauma, partial resection or bypass of the small bowel,
carrageenan-induced inflammation or colonic infection with
Citrobacter freundii, potentiate colonic carcinogenesis
(latropoulos et al., 1975; Pozharisski, 1975; Williamson et
al., 1980; Barthold, 1983; Farber, 19s7). Colitis produces an
increase in the rate of colonic cell turnover (Serafini et al.,
1981) and experimental murine colitis produced by
chemotactic peptides augments colonic cancer induced by
1,2-dimethylhydrazine (DMH) when active colitis and
administration of DMH coincide (Chester et al., 1986). To
see whether colitis produced by chemotactic peptides could
act as a promoter of experimental colonic cancer, we
produced experimental colitis in mice after a period of
tumour induction with DMH.
Male CDI mice (Charles River Laboratories, Wilmington,
MA; n=94; age 35 days) were housed with a 12h light-dark
cycle and were given free access to Purina Rat Chow and
water. 1,2-dimethylhydrazine (DMH) (Aldrich Chemical Co.,
Milwaukee, WI, USA) was dissolved in ethylenediamine-
tetraacetic acid disodium salt (0.001 M EDTA) and was
brought to pH 6.5 by addition of sodium hydroxide. Formyl-
norleucyl-leucyl-phenylalanine (FNLP) (Sigma Chemical Co.,
St Louis, MO, USA) was dissolved in 6% dimethyl-
sulphoxide (DMSO) in normal saline solution to a final
concentration of 10mM at pH 8.0.
A model for acute colitis in mice using peptides chemo-
tactic for polymorphonuclear leukocytes was used in these
experiments (Chester et al., 1985).
Mice anaesthetised by intramuscular injections of ketamine
50mgkg-1 underwent weekly rectal instillations of 10mM
FNLP in 6% DMSO in saline solution or of DMSO in
saline alone (control enemas). Enemas were delivered
through a lubricated 14F urethral catheter inserted 2cm into
the rectum. Each catheter remained in position for 1.5h,
additional anaesthetic being given as necessary. Rectal
catheters were removed at 1.5h, since colonic exposure to
10mm FNLP for longer than 2h causes 100% mortality
(Chester et al., 1985). Solutions of 0.8ml FNLP or DMSO
were instilled initially and a further 0.3ml was instilled after
45min. FNLP-treated mice developed acute colitis
characterised by oedema and neutrophilic infiltration. No
neutrophilic infiltration occurred in the colons of animals
treated with control enemas.
Mice were acclimatised and divided among three groups to
receive DMH +FNLP (n =40), DMH +control enemas
(n =39) and FNLP alone (n = 15). Groups assigned to receive
DMH received six subcutaneous injections of DMH
(15mgkg-1 in 0.25ml EDTA solution) at weekly intervals.
The remaining mice received equivalent volumes of EDTA
solution (control injections). Three days after the last
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injection of DMH or EDTA, all animals received the first of
seven enemas of FNLP or of control solutions at weekly
intervals.
Twenty-nine mice died before the end of the experiment
from anaesthetic complications (n=5), DMH-induced
hepatotoxicity (n=6), or colonic distension or perforation
(n= 18). Although nearly half of the group receiving
DMH +FNLP died before the end of the experiment (Table
I), FNLP itself has not been found to have toxic effects
other than those associated with production of inflam-
mation. Portal bacteraemia and endotoxaemia may,
however, have complicated the colonic inflammation induced
by FNLP, thereby increasing mortality. Autolysis prevented
histological examination of six colons. Surviving mice were
sacrificed 21 weeks after their last DMH or EDTA injection.
The entire colon was remolved in continuity, flushed clean
with saline solution, laid open and examined under a
dissecting microscope. All abnormal areas were removed and
fixed in 10% formalin. Coded specimens were stained with
Haematoxylin and Eosin for histological examination. The
x2 test was then used for comparison of tumour-bearing
animals.
All surviving mice appeared healthy and gained weight
throughout the experiment. Sixty-nine per cent (64/94)
survived to the end of 21 weeks after their last DMH or
EDTA injection. Colitis was confirmed in the colons of two
mice dying shortly after the last of the FNLP enemas. One
of these mice had received FNLP alone; the second had
received DMH+FNLP and in addition to marked colonic
neutrophilic infiltration, developed a solitary adenocar-
cinoma in the descending colon. This neoplasm was included
in the count of tumours at the end of the experiment.
Colonic neoplasms occurred only in the distal half of the
colon. Twenty-one weeks after completion of the DMH
course, adenocarcinomas were found in the colon of 23% of
mice assigned to receive DMH+FNLP versus only 3%
assigned to DMH+control enemas (P=0.025) (Table I).
None of the mice developed multiple tumours, and no
Table I Incidence, number and invasiveness of neoplasms in mice
14 weeks after six initial weekly injections of DMH or EDTA and
seven subsequent weekly FNLP of control enemas.
DMH+control FNLP
Category DMH+FNLP enemas alone
Original number of mice 40 39 15
Final number of mice 22 34 9
Number of mice with
tumours 1a I 0
Number of mice without
tumours 17 33 9
Total tumour number 5 1 0
Number of tumours
showing invasion 0 1 0
ap= 0.025 (comparison of groups treated with DMH+FNLP and
DMH+control enemas). This figure includes one neoplasm found in
the colon of an animal dying after the last of a course of FNLP
enemas.
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tumours occurred in animals assigned to receive FNLP
alone.
Mechanisms contributing to cancer production in inflamed
tissues may include an increase in cellular proliferation in
response to epithelial injury and cell death (Barthold, 1983)
and the release of toxic oxygen metabolites from phagocytic
leukocytes, with resultant cellular injury, mutation and
possible malignant transformation (Weitzman et al., 1981,
1985). Although in vitro observations support the hypothesis
that phagocyte-derived oxidising species might function as
complete carcinogens (Weitzman et al., 1985), the relative in
vivo contributions of cellular proliferation and of oxidant
injury to the carcinogenic process have not been resolved.
Oxygen free-radicals are essential for promotion of some
tumours in the mouse skin (Troll et al., 1984; Cerutti, 1985).
In the model studied, colonic inflammation and, possibly,
free radicals promoted carcinogenesis in the mouse colon
also. Although an additive effect of DMH and colitis
remains a possibility, it is unlikely because chemotactic
peptide-induced colitis in the absence of DMH does not
produce tumours (Chester et al., 1986).
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